Globus Medical (GMED) Q3: revenue below estimates, EPS above consensus
FROM THE WIRE · FINANCE.YAHOO.COM
Globus Medical (GMED) reported $763.72 million in revenue for the quarter ended September 2026, representing a year-over-year decline of 0.7%. EPS of $1.23 for the same period compares to $1.18 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $792.96…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe revenue miss matters for this medical device mid-cap, while the EPS beat limits the downside.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue of $763.72 million in the quarter ended September 2026, down 0.7% year over year.
- 02Revenue came in below the Zacks Consensus Estimate of $792.96 million, a surprise of -3.69%.
- 03EPS of $1.23 beat the $1.20 consensus estimate, a surprise of +2.5%.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets